Articles from BIOTECH Patent News (March 1, 2009)

Title	Author	Type	Words
Agriculture and Agri - Food Canada obtains United States patent.			109
Amicus Therapeutics Announces Issuance of New Plicera Composition of Matter Patent.			309
Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International.			208
Appeals Court Affirms That J&J Stents Infringe Boston Scientific Patent.			238
BASF obtains United States patent.			84
Canadian Minister of Agriculture and Agri-Food obtains United States patent.			117
CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors.			571
Despite Patent Expiries of Leading Therapies, New Product Launches Will Drive a $4.6 Billion Increase in the Coronary Heart Disease Market.			354
Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement.			303
Human Genome Sciences and Morphotek, Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology.			817
Immunotech Completes Merger Acquisition.			221
Immunotherapy-Based Provisional Patents Mark Significant Discovery.			530
Independent Study Corroborates Prana's Strategy to Treat Alzheimer's Disease Patients.			475
Institute of Virology, Slovak Academy of Sciences obtains United States patent.			148
Microfluidic Systems is Granted a Microfluidic Cartridge Patent for DNA Separation.			265
Patent for Making Combination Chemotherapy Work Better.			362
Peregrine Pharmaceuticals Awarded New United States Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio.			444
Repligen Licenses Patent Rights for Treatment of Bipolar Disorder.			594
Senomyx obtains United States patent.			111
Stresspro Biomedicine obtains United States patent.			135
Therapure Biopharma obtains United States patent.			80
University of North Texas Health Science Center at Fort Worth obtains United States patent.			167
University of Prince Edward Island obtains United States patent.			126